Clinical Trials on 疱疹病毒 2,人类 in United Kingdom
总计7166个结果
-
AstraZeneca完全的
-
AstraZenecaEli Lilly and Company完全的
-
Louisville Metabolic and Atherosclerosis Research...California Raisin Marketing Board完全的
-
Kaiser Permanente撤销
-
GlaxoSmithKline完全的
-
Johns Hopkins Bloomberg School of Public HealthAmerican Diabetes Association完全的
-
Sanofi完全的
-
AstraZenecaBristol-Myers Squibb完全的
-
AstraZenecaBristol-Myers Squibb完全的
-
AstraZenecaBristol-Myers Squibb终止
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Baylor College of Medicine完全的
-
Kaiser PermanenteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Oregon Research Institute 和其他合作者完全的
-
AstraZeneca完全的
-
Ligand PharmaceuticalsMedpace, Inc.; Beckloff Associates, Inc.完全的
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)完全的
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute终止
-
King's College LondonQueen Mary University of London; University of Liverpool完全的
-
Lexicon PharmaceuticalsSanofi完全的2 型糖尿病美国, 保加利亚, 爱沙尼亚, 匈牙利, 大韩民国, 波兰, 罗马尼亚, 斯洛伐克, 乌克兰, 英国